Sequenom Faces Suit Over Mishandled Test Data

Law360, New York (May 4, 2009, 12:00 AM EDT) -- Sequenom Inc. is facing a proposed securities class action over its announcement that employees have mishandled testing data for a new prenatal test the genetic analysis company has developed to screen for Down syndrome.

The suit, filed Friday in the U.S. District Court for the Southern District of California, claims San Diego-based Sequenom and five executives inflated the company's stock price by making false statements about test data and results for the product.

Sequenom announced Wednesday that it could no longer rely on the test data...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.